<DOC>
	<DOCNO>NCT00345618</DOCNO>
	<brief_summary>Objectives evaluate whether idrabiotaparinux sodium ( SSR126517E ) least effective standard warfarin treatment prevent recurrence venous thromboembolic event ( VTE ) patient symptomatic pulmonary embolism ( PE ) without symptomatic deep venous thrombosis ( DVT ) ass safety ( bleeding ) versus warfarin .</brief_summary>
	<brief_title>Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly Pulmonary Embolism Therapeutic Approach</brief_title>
	<detailed_description>Treatment therapeutic dose low molecular weight heparin ( LMWH ) unfractioned heparin ( UFH ) fondaparinux allow within 36 hour immediately precede randomization . Randomization perform soon diagnosis PE ( DVT concomitant suspect symptomatic DVT ) confirm . Allocation treatment do centrally Interactive Voice Response System ( IVRS ) stratify ( 1 ) center , ( 2 ) intend treatment duration , ie , 3 month 6 month . At randomization , plan duration treatment ( 3 6 month ) prespecified Investigator determine assessment risk VTE recurrence . Participants randomize either idrabiotaparinux + placebo warfarin , warfarin + placebo idrabiotaparinux , initial treatment least 5 day enoxaparin treatment group . Participants 3-month stratum additional 13-week observational period cessation study treatment . Participants 6-month stratum 13-week 26-week observational period .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Biotin</mesh_term>
	<criteria>Symptomatic pulmonary embolism without symptomatic deep vein thrombosis End stage renal failure , hepatic failure , uncontrolled hypertension ; Active bleeding high risk bleeding ; Pregnancy childbearing potential without proper contraceptive measure , threaten abortion . Breastfeeding . Known allergy idraparinux idrabiotaparinux , avidin egg protein ; hypersensitivity warfarin , enoxaparin , heparin pork product ; contraindication list label warfarin enoxaparin ; Indication prolong anticoagulation therapy reason PE ; Life expectancy &lt; 6 month ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Deep venous thrombosis</keyword>
	<keyword>pulmonary embolism</keyword>
	<keyword>anticoagulant drug</keyword>
</DOC>